Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 6,335,000 | 5,333,000 | 5,302,000 | 5,333,000 | 4,885,000 |
| Cost of Goods | 3,062,000 | 2,382,000 | 2,285,000 | 2,287,000 | 2,140,000 |
| Gross Profit | 3,273,000 | 2,951,000 | 3,017,000 | 3,046,000 | 2,745,000 |
| Operating Expenses | 3,515,000 | 2,162,000 | 2,120,000 | 2,230,000 | 2,221,000 |
| Operating Income | -242,000 | 789,000 | 897,000 | 816,000 | 524,000 |
| Interest Expense | 226,000 | 153,000 | 117,000 | 103,000 | 58,000 |
| Other Income | 1,204,000 | 239,000 | -959,000 | 2,000 | -464,000 |
| Pre-tax Income | 736,000 | 875,000 | -179,000 | 715,000 | 2,000 |
| Income Tax | 350,000 | 110,000 | 178,000 | 116,000 | -54,000 |
| Net Income Continuous | 386,000 | 765,000 | -357,000 | 599,000 | 56,000 |
| Net Income Discontinuous | 33,000 | 33,000 | 28,000 | 16,000 | 260,000 |
| Net Income | $419,000 | $798,000 | $-329,000 | $615,000 | $316,000 |
| EPS Basic Total Ops | 0.24 | 0.54 | -0.22 | 0.41 | 0.21 |
| EPS Basic Continuous Ops | 0.22 | 0.51 | -0.24 | 0.40 | 0.04 |
| EPS Basic Discontinuous Ops | 0.02 | 0.03 | 0.02 | 0.01 | 0.17 |
| EPS Diluted Total Ops | 0.24 | 0.54 | -0.22 | 0.41 | 0.21 |
| EPS Diluted Continuous Ops | 0.22 | 0.52 | -0.24 | 0.40 | 0.04 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.03 | 0.02 | 0.01 | 0.17 |
| EBITDA(a) | $924,000 | $1,273,000 | $1,237,000 | $1,163,000 | $871,000 |